Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial.
- DOI
- 10.1136/rmdopen-2022-002303
- Published
- 2022 Jul
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2022-002303,
title = {Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial.},
author = {Baraliakos X and Pournara E and Gossec L and Mease PJ and White R and O'Brien E and Schulz B and Marzo-Ortega H and Coates LC},
year = {2022},
journal = {RMD open},
doi = {10.1136/rmdopen-2022-002303},
url = {https://doi.org/10.1136/rmdopen-2022-002303}
}RIS
TY - JOUR TI - Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial. AU - Baraliakos X AU - Pournara E AU - Gossec L AU - Mease PJ AU - White R AU - O'Brien E AU - Schulz B AU - Marzo-Ortega H AU - Coates LC PY - 2022 JO - RMD open DO - 10.1136/rmdopen-2022-002303 UR - https://doi.org/10.1136/rmdopen-2022-002303 ER -
APA
X, B., E, P., L, G., PJ, M., R, W., E, O., B, S., H, M., & LC, C. (2022). Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial.. RMD open. https://doi.org/10.1136/rmdopen-2022-002303
Source records
- pubmed · retrieved 2026-09-25T12:11:13.028Z